Istituti Clinici Scientifici Maugeri IRCCS,

Pavia 27100

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER2 Positive Breast Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study — Completed